Antibody maintenance and breakthrough infections 6 months after complete COVID-19 vaccination with the mRNA-1273 and BNT162b2 vaccines in hemodialysis patients
Clin Kidney J
.
2021 Dec 16;15(4):818-819.
doi: 10.1093/ckj/sfab282.
eCollection 2022 Apr.
Authors
Diana Rodríguez-Espinosa
1
,
José Jesús Broseta
1
,
José Luis Bedini
2
,
Néstor Rodríguez
3
,
Francisco Maduell
1
Affiliations
1
Department of Nephrology and Renal Transplantation, Hospital Clínic of Barcelona, Barcelona, Spain.
2
Department of Biochemistry and Molecular Genetics, Hospital Clínic of Barcelona, Barcelona, Spain.
3
Diaverum Renal Services Haemodialysis Group, Barcelona, Spain.
PMID:
35371449
PMCID:
PMC8967668
DOI:
10.1093/ckj/sfab282
No abstract available